Markets

AngioDynamics (ANGO) in Focus: Stock Falls 6.7%

AngioDynamics Inc.ANGO saw a big move last session, as the company's shares fell by almost 7% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the recent downtrend for ANGO, as the stock is now down almost 16% in the past one-month time frame.

On Oct 8, 2015, the company posted first quarter of fiscal 2016 results, where adjusted earnings of 11 cents per share for the were in line with the Zacks Consensus Estimate, but plunged 31.3% on a year-over-year basis. Sales declined 4.2% year over year and also lagged estimates.

The medical devices provider has seen a mixed track record when it comes to current year estimate revisions over the past few weeks (0 increases, 2 decreases), and the consensus for earnings hasn't been in a trend either. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.

ANGO currently has a Zacks Rank #4 (Sell).

Investors interested in the Medical Instruments industry may consider better-ranked stock like Cesca Therapeutics Inc. KOOL , which carries a Zacks Rank #1 (Strong Buy).

Is ANGO going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

ANGIODYNAMICS (ANGO): Free Stock Analysis Report

CESCA THERAP (KOOL): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

THMO ANGO

Other Topics

Investing Stocks

Latest Markets Videos

Zacks

Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

Learn More